Case report: Therapy adherence, MTTP variants, and course of atheroma in two patients with HoFH on low-dose, long-term lomitapide therapy
Background: Homozygous familial hypercholesterolemia (HoFH) is a rare and devastating genetic condition characterized by extremely elevated levels of low-density lipoprotein cholesterol (LDL-C) leading to an increased risk of premature atherosclerosis. Patients with Homozygous familial hypercholeste...
Päätekijät: | , , , , |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Frontiers Media S.A.
2023-01-01
|
Sarja: | Frontiers in Genetics |
Aiheet: | |
Linkit: | https://www.frontiersin.org/articles/10.3389/fgene.2022.1087089/full |